Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential

Authors:

Abstract
(2010). Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opinion on Therapeutic Targets: Vol. 14, No. 2, pp. 207-219.

This publication has 90 references indexed in Scilit: